ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

WCRX Warner Chilcott

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type Share ISIN Share Description
Warner Chilcott LSE:WCRX London Ordinary Share GB0000404482 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results

14/07/2009 8:00pm

PR Newswire (US)


Warner Chilcott (LSE:WCRX)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Warner Chilcott Charts.
ARDEE, Ireland, July 14 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its second quarter 2009 financial results prior to the market opening on Friday, August 7, 2009. In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, August 7, 2009 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (888) 208-1812 in the United States and Canada or (719) 325-2339 internationally. Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com/ and clicking on Events & Presentations. A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 6093247. The Company Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F DATASOURCE: Warner Chilcott Limited CONTACT: Rochelle Fuhrmann, Investor Relations for Warner Chilcott, +1-973-442-3281, Web Site: http://ir.wcrx.com/

Copyright

1 Year Warner Chilcott Chart

1 Year Warner Chilcott Chart

1 Month Warner Chilcott Chart

1 Month Warner Chilcott Chart

Your Recent History

Delayed Upgrade Clock